Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Campos M, Pereira N, Laranjo M, Nascimento B, Brites G, Piñeiro M, Botelho M. PO-422 Disagregation in biological medium of promising theranostic agents for cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.448] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open

For:	Campos M, Pereira N, Laranjo M, Nascimento B, Brites G, Piñeiro M, Botelho M. PO-422 Disagregation in biological medium of promising theranostic agents for cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.448] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open

Number	Cited by Other Article(s)
1	Shahrivari S, Aminoroaya N, Ghods R, Latifi H, Afjei SA, Saraygord-Afshari N, Bagheri Z. Toxicity of trastuzumab for breast cancer spheroids: Application of a novel on-a-chip concentration gradient generator. Biochem Eng J 2022. [DOI: 10.1016/j.bej.2022.108590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Shahrivari S, Aminoroaya N, Ghods R, Latifi H, Afjei SA, Saraygord-Afshari N, Bagheri Z. Toxicity of trastuzumab for breast cancer spheroids: Application of a novel on-a-chip concentration gradient generator. Biochem Eng J 2022. [DOI: 10.1016/j.bej.2022.108590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]